MedinCell notes approval of UZEDY in South Korea (€18.67, 0.00)
FDA issues new guidance to expand non-opioid options for chronic pain
Teva's Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
StreetAccount Sector Summary: Healthcare Monthly Recap - August 2025
Powered by FactSet Research Systems Inc.